Over 16,536,722 people are on fubar.
What are you waiting for?
The Food and Drug Administration continues to have concerns that a weight-loss drug it is reviewing for the second time can cause birth defects and heart problems, documents released by the agency on Friday show- mulberry bags for sale . The agency appears to be increasingly concerned about assessing the tangible benefits of weight loss in terms of improving health and quality of life. Dr. Janet Woodcock, the F.D.A.’s top drug reviewer, mentioned this emerging view in a talk at an investor conference on Thursday. Vivus, which is based in Mountain View, Calif., argues that in addition to losing weight, users of Qnexa in the clinical trials had improvements in blood sugar, blood pressure, cholesterol and some other health measures, compared with those who got the placebo- mulberry sale . Instead, the agency and Vivus are discussing ways of keeping pregnant women from using the drug. That, however, could be difficult. In the clinical trials, women had to use rigorous contraception and undergo frequent pregnancy testing. Yet there were still 34 pregnancies. In the 19 of those pregnancies carried to term, there were no known major birth defects- mulberry bags for sale
.
